Elena Rama

Elena Rama

Auto-generated profile, based on publicly available information

Elena Rama

Institute for Experimental Molecular Imaging, Faculty of Medicine, RWTH Aachen University, Forckenbeckstraße 55, 52074 Aachen, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Biomaterials
Verified
Journal Article
Closed access
VPVertika Pathak
Vertika Pathak
TNTeresa Nolte
Teresa Nolte
ERElena Rama
Elena Rama
ARAnne Rix
Anne Rix
SDSeyed Mohammadali Dadfar
Seyed Mohammadali Dadfar
Fabian KiesslingFabian Kiessling
Fabian Kiessling

4 February 2022 in Advanced Science
Verified
Journal Article
Open access
PDF file
ERElena Rama
Elena Rama
SMSaurav Ranjan Mohapatra
Saurav Ranjan Mohapatra
CMChristoph Melcher
Christoph Melcher
TNTeresa Nolte
Teresa Nolte
SDSeyed Mohammadali Dadfar
Seyed Mohammadali Dadfar
Fabian KiesslingFabian Kiessling
Fabian Kiessling
Tissue‐engineered vascular grafts (TEVGs) with the ability to grow and remodel open new perspectives for cardiovascular surgery. Equipping TEVGs with synthetic polymers and biological components provides a good compromise between high structural stability and biological adaptability. However, imaging approaches to control grafts’ structural integrity, physiological function, and remodeling during the entire transition between late in vitro maturation and early in vivo engraftment are mandatory for clinical implementation. Thus, a comprehensive molecular imaging concept using magnetic resonance imaging (MRI) and ultrasound (US) to monitor textile scaffold resorption, extracellular matrix (ECM) remodeling, and endothelial integrity in TEVGs is presented here. Superparamagnetic iron‐oxide nanoparticles (SPION) incorporated in biodegradable poly(lactic‐co‐glycolic acid) (PLGA) fibers of the TEVGs allow to quantitatively monitor scaffold resorption via MRI both in vitro and in vivo. Additionally, ECM formation can be depicted by molecular MRI using elastin‐ and collagen‐targeted probes. Finally, molecular US ofαvβ3integrins confirms the absence of endothelial dysfunction; the latter is provocable by TNF‐α. In conclusion, the successful employment of noninvasive molecular imaging to longitudinally evaluate TEVGs remodeling is demonstrated. This approach may foster its translation from in vitro quality control assessment to in vivo applications to ensure proper prostheses engraftment.

17 June 2024 in Biomaterials
Verified
Journal Article
Open access
ERElena Rama
Elena Rama
SMSaurav Ranjan Mohapatra
Saurav Ranjan Mohapatra
YSYukiharu Sugimura
Yukiharu Sugimura
TSTomoyuki Suzuki
Tomoyuki Suzuki
SSStefan Siebert
Stefan Siebert
Fabian KiesslingFabian Kiessling
Fabian Kiessling
Biohybrid tissue-engineered vascular grafts (TEVGs) promise long-term durability due to their ability to adapt to hosts' needs. However, the latter calls for sensitive non-invasive imaging approaches to longitudinally monitor their functionality, integrity, and positioning. Here, we present an imaging approach comprising the labeling of non-degradable and degradable TEVGs' components for their in vitro and in vivo monitoring by hybrid 1H/19F MRI. TEVGs (inner diameter 1.5 mm) consisted of biodegradable poly(lactic-co-glycolic acid) (PLGA) fibers passively incorporating superparamagnetic iron oxide nanoparticles (SPIONs), non-degradable polyvinylidene fluoride scaffolds labeled with highly fluorinated thermoplastic polyurethane (19F-TPU) fibers, a smooth muscle cells containing fibrin blend, and endothelial cells. 1H/19F MRI of TEVGs in bioreactors, and after subcutaneous and infrarenal implantation in rats, revealed that PLGA degradation could be faithfully monitored by the decreasing SPIONs signal. The 19F signal of 19F-TPU remained constant over weeks. PLGA degradation was compensated by cells' collagen and α-smooth-muscle-actin deposition. Interestingly, only TEVGs implanted on the abdominal aorta contained elastin. XTT and histology proved that our imaging markers did not influence extracellular matrix deposition and host immune reaction. This concept of non-invasive longitudinal assessment of cardiovascular implants using 1H/19F MRI might be applicable to various biohybrid tissue-engineered implants, facilitating their clinical translation.